These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32859329)

  • 1. The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial.
    Abhari K; Saadati S; Yari Z; Hosseini H; Hedayati M; Abhari S; Alavian SM; Hekmatdoost A
    Clin Nutr ESPEN; 2020 Oct; 39():53-60. PubMed ID: 32859329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
    Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
    Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.
    Eslamparast T; Poustchi H; Zamani F; Sharafkhah M; Malekzadeh R; Hekmatdoost A
    Am J Clin Nutr; 2014 Mar; 99(3):535-42. PubMed ID: 24401715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases.
    Shinde T; Perera AP; Vemuri R; Gondalia SV; Beale DJ; Karpe AV; Shastri S; Basheer W; Southam B; Eri R; Stanley R
    Eur J Nutr; 2020 Dec; 59(8):3669-3689. PubMed ID: 32067099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Bakhshimoghaddam F; Shateri K; Sina M; Hashemian M; Alizadeh M
    J Nutr; 2018 Aug; 148(8):1276-1284. PubMed ID: 29931231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial.
    Darabi Z; Darand M; Yari Z; Hedayati M; Faghihi A; Agah S; Hekmatdoost A
    BMC Res Notes; 2019 Feb; 12(1):89. PubMed ID: 30767788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Synbiotic-Containing Bacillus coagulans (GBI-30) on the Cardiovascular Status of Patients With Polycystic Ovary Syndrome: A Triple-blinded, Randomized, Placebo-controlled Study.
    Hariri Z; Yari Z; Hoseini S; Mehrnami A; Abhari K; Sohrab G
    Clin Ther; 2023 Oct; 45(10):e193-e199. PubMed ID: 37640616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
    Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
    Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Cheraghpour M; Imani H; Ommi S; Alavian SM; Karimi-Shahrbabak E; Hedayati M; Yari Z; Hekmatdoost A
    Phytother Res; 2019 Aug; 33(8):2118-2125. PubMed ID: 31264313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease.
    Sayari S; Neishaboori H; Jameshorani M
    Clin Mol Hepatol; 2018 Sep; 24(3):331-338. PubMed ID: 29890569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synbiotic Supplementation Containing Whole Plant Sugar Cane Fibre and Probiotic Spores Potentiates Protective Synergistic Effects in Mouse Model of IBD.
    Shinde T; Perera AP; Vemuri R; Gondalia SV; Karpe AV; Beale DJ; Shastri S; Southam B; Eri R; Stanley R
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 30979002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Synbiotic Supplementation on Metabolic Status in Diabetic Patients Undergoing Hemodialysis: a Randomized, Double-Blinded, Placebo-Controlled Trial.
    Soleimani A; Motamedzadeh A; Zarrati Mojarrad M; Bahmani F; Amirani E; Ostadmohammadi V; Tajabadi-Ebrahimi M; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1248-1256. PubMed ID: 30560426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial.
    Zeinali F; Aghaei Zarch SM; Vahidi Mehrjardi MY; Kalantar SM; Jahan-Mihan A; Karimi-Nazari E; Fallahzadeh H; Hosseinzadeh-Shamsi-Anar M; Rahmanian M; Fazeli MR; Mozaffari-Khosravi H
    Trials; 2020 Apr; 21(1):324. PubMed ID: 32290852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
    Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
    Br J Nutr; 2020 Aug; 124(4):450-456. PubMed ID: 32312333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Salehi-Sahlabadi A; Kord-Varkaneh H; Kocaadam-Bozkurt B; Seraj SS; Alavian SM; Hekmatdoost A
    Phytother Res; 2022 Nov; 36(11):4201-4209. PubMed ID: 35843540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial.
    Asemi Z; Alizadeh SA; Ahmad K; Goli M; Esmaillzadeh A
    Clin Nutr; 2016 Aug; 35(4):819-25. PubMed ID: 26209256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial.
    Hariri Z; Yari Z; Hoseini S; Abhari K; Sohrab G
    BMC Womens Health; 2024 Jan; 24(1):19. PubMed ID: 38172876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
    Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
    J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.